Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Authors:
  • RERaimund Erbel
    Raimund Erbel
  • PEPaul Erne
    Paul Erne
  • SVStefan Verheye
    Stefan Verheye
  • HDHubertus Degen
    Hubertus Degen
  • DBDirk Böse
    Dirk Böse
  • PVPaul Vermeersch
    Paul Vermeersch
  • IWInge Wijnbergen
    Inge Wijnbergen
  • NWNeil Weissman
    Neil Weissman
  • FPFrancesco Prati
    Francesco Prati
  • RWRon Waksman
    Ron Waksman
  • JKJacques Koolen
    Jacques Koolen

Abstract
No abstract available

This publication has 29 references indexed in Scilit: